logo
Select company
Select metric
$ -2.97EBITDA per Share
VS
Market
8
Sector
22
Industry
29
History
-
$ 0.62Close
$ 0.36 - $ 4.96 52-Week Range
Ticker Information

Ticker

IBO

Company Name

IMPACT BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

IMPACT BIOMEDICAL INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IBO - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -36.2M$ -2.97112.19M
3/31/2025$ -22.75M$ -1.89112.06M
12/31/2024$ -22.49M$ -2.09110.76M
9/30/2024$ 3.2M$ 0.28111.5M
6/30/2024$ -2.41M$ -0.24110M
3/31/2024$ 0$ 0110M
12/31/2023$ -2.77M$ -0.05160.25M
9/30/2023$ 0$ 0170.5M
6/30/2023$ 0$ 0170.5M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMPACT BIOMEDICAL INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
  • Over the past 5 years, IMPACT BIOMEDICAL INC's average EBITDAPS has been $ -1.16.
  • The median EBITDAPS for IMPACT BIOMEDICAL INC during this period was $ -1.06
  • IMPACT BIOMEDICAL INC reached its highest EBITDAPS over the past 5 years at $ 0.28.
  • The lowest EBITDAPS recorded by IMPACT BIOMEDICAL INC in the same timeframe $ -2.97

IMPACT BIOMEDICAL INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ -2.19TCRT : ALAUNOS THERAPEUTICS INC $ -2.38ADTX : ADITXT INC $ -14.17HSCS : HEARTSCIENCES INC $ -6.12PMCB : PHARMACYTE BIOTECH INC $ -0.17APVO : APTEVO THERAPEUTICS INC $ -32.19PALI : PALISADE BIO INC $ -2.44ACXP : ACURX PHARMACEUTICALS INC $ -8.4GNPX : GENPREX INC $ -0.63TTNP : TITAN PHARMACEUTICALS INC $ -2.63

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for IMPACT BIOMEDICAL INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 70.5M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]

IBO - EBITDA per Share, Last 5 years

$ -2.97

Minimum

Jun 30, 2025

$ 0.28

Maximum

Sep 30, 2024

$ -1.16

Average

$ -1.06

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28